Strategy At Novartis: Culture Change As The 'How' Behind The 'What'
Executive Summary
If strategic planning is a necessary hedge against the drawn-out, asset-draining product cycles of today’s big pharma enterprise, then what is the secret of doing it well? Scrip looks for answers in a conversation with Novartis strategy lead Stephen Moran.